News Home

Analyst Rating: Will Sio Gene Therapies Inc (SIOX) Stock Outperform the Market?

Tuesday, February 16, 2021 11:24 AM | InvestorsObserver Analysts
Analyst Rating: Will Sio Gene Therapies Inc (SIOX) Stock Outperform the Market?

InvestorsObserver is giving Sio Gene Therapies Inc (SIOX) an Analyst Rating Rank of 65, meaning SIOX is ranked higher by analysts than 65% of stocks. The average price target for SIOX is $8.875 and analyst’s rate the stock as a Strong Buy

Overall Score - 4.6
Wall Street analysts are rating SIOX a Strong Buy today. Find out what this means to you and get the rest of the rankings on SIOX!

Why are Analyst Ratings Important?

You can learn a lot about a company from looking at it’s financial statements and comparing them to other companies. Analysts who cover an industry in depth can add even more to your research though. They typically follow a particular sector or industry very closely. They also pay attention to and ask questions on earnings conference calls and other events where they might learn information that does show up in the numbers.

InvestorsObserver takes the average rating from these analysts, and then percentile ranks those averages. This lets you compare stocks in a much more granular way than just seeing the typical five-tiered rating system used on most of Wall Street.

What's Happening With Sio Gene Therapies Inc Stock Today?

Sio Gene Therapies Inc (SIOX) stock is trading at $3.35 as of 11:22 AM on Tuesday, Feb 16, a rise of $0.04, or 1.21% from the previous closing price of $3.31. The stock has traded between $3.24 and $3.45 so far today. Volume today is low. So far 848,833 shares have traded compared to average volume of 1,542,598 shares.

Click Here to get the full report on Sio Gene Therapies Inc (SIOX) Stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App